Literature DB >> 27161221

HuangQi Decoction Ameliorates Renal Fibrosis via TGF-β/Smad Signaling Pathway In Vivo and In Vitro.

Jie Zhao, Li Wang, Ai-Li Cao, Ming-Qian Jiang, Xia Chen, Yi Wang, Yun-Man Wang, Hao Wang, Xue-Mei Zhang, Wen Peng.   

Abstract

OBJECTIVE: Traditional Chinese Medicine compound HuangQi decoction is widely used in clinical treatment of chronic kidney disease, but its role on renal interstitial fibrosis and the underlying mechanism remains unclear. The aim of this study is to investigate the effect of HuangQi decoction on renal interstitial fibrosis and its association with the TGF-β/Smad signaling pathway
Methods: A total of 120 C57/BL mice were randomly divided into six groups: sham group, sham plus high-dose HuangQi decoction (1.08g/kg) group, unilateral ureteral obstruction (UUO) model group, and UUO model plus low to high doses of HuangQi decoction (0.12g/kg, 0.36g/kg and 1.08g/kg respectively) groups. Animals were sacrificed 14 days after the administration and ipsilateral kidney tissue was sampled for pathologic examinations. Immunohistochemistry, PCR and western blot were used to detect the expressions of related molecules in the TGF-β/Smad signaling pathway. TGF-β1 was used in in vitro experiments to induce human kidney proximal tubule epithelial cells (HK2).
RESULTS: HuangQi decoction improved ipsilateral kidney fibrosis in UUO mice and downregulated the expressions of TGF-β1, TβRI, TβRII, Smad4, Smad2/3, P-Smad2/3, α-SMA, collagen type I, III and IV in a dose-dependent manner while upregulated the expression of Smad7 in the same fashion. Similar results were found in in vitro studies.
CONCLUSION: The protective effect of HuangQi decoction for unilateral ureteral obstruction kidney damage in mice was mediated by downregulating the TGF-β/Smad signaling pathway.
© 2016 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27161221     DOI: 10.1159/000443115

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  10 in total

Review 1.  Research Progress of Chinese Herbal Medicine Intervention in Renal Interstitial Fibrosis.

Authors:  Xiao-Yuan Liu; Xu-Bin Zhang; Ya-Feng Zhao; Kai Qu; Xiao-Yong Yu
Journal:  Front Pharmacol       Date:  2022-06-13       Impact factor: 5.988

2.  NiaoDuQing granules relieve chronic kidney disease symptoms by decreasing renal fibrosis and anemia.

Authors:  Xu Wang; Suyun Yu; Qi Jia; Lichuan Chen; Jinqiu Zhong; Yanhong Pan; Peiliang Shen; Yin Shen; Siliang Wang; Zhonghong Wei; Yuzhu Cao; Yin Lu
Journal:  Oncotarget       Date:  2017-06-14

3.  Microarray analysis reveals gene and microRNA signatures in diabetic kidney disease.

Authors:  Chengji Cui; Yabin Cui; Yanyan Fu; Sichao Ma; Shoulin Zhang
Journal:  Mol Med Rep       Date:  2017-11-28       Impact factor: 2.952

4.  MicroRNA-423-5p facilitates hypoxia/reoxygenation-induced apoptosis in renal proximal tubular epithelial cells by targeting GSTM1 via endoplasmic reticulum stress.

Authors:  Xiao-Peng Yuan; Long-Shan Liu; Chuan-Bao Chen; Jian Zhou; Yi-Tao Zheng; Xiao-Ping Wang; Ming Han; Chang-Xi Wang
Journal:  Oncotarget       Date:  2017-05-30

5.  N6-(2-Hydroxyethyl) Adenosine From Cordyceps cicadae Ameliorates Renal Interstitial Fibrosis and Prevents Inflammation via TGF-β1/Smad and NF-κB Signaling Pathway.

Authors:  Rong Zheng; Rong Zhu; Xueling Li; Xiaoyun Li; Lianli Shen; Yi Chen; Yifei Zhong; Yueyi Deng
Journal:  Front Physiol       Date:  2018-09-04       Impact factor: 4.566

6.  Combination of Ginsenoside Rg1 and Astragaloside IV reduces oxidative stress and inhibits TGF-β1/Smads signaling cascade on renal fibrosis in rats with diabetic nephropathy.

Authors:  Na Du; Zhiping Xu; Mingyue Gao; Peng Liu; Bo Sun; Xia Cao
Journal:  Drug Des Devel Ther       Date:  2018-10-18       Impact factor: 4.162

7.  siRNA-silencing of CD40 attenuates unilateral ureteral obstruction-induced kidney injury in mice.

Authors:  Alonso Narváez; Roser Guiteras; Anna Sola; Anna Manonelles; Juan Morote; Juan Torras; Josep M Grinyó; Josep M Cruzado
Journal:  PLoS One       Date:  2019-04-12       Impact factor: 3.240

8.  Niao Du Kang Mixture Increases the Expression of mir-129-5p to Relieve Renal Fibrosis.

Authors:  Yan-Lin Li; Lin-Na Liu; Lin Huang; Hai-Wen An; Jian-Lin Jian; Jie Pang; Fen-Na Lin; Wen-Qin Yang; Jin-Shan Li; Qian Jiang; Hong Wang
Journal:  Evid Based Complement Alternat Med       Date:  2020-05-04       Impact factor: 2.629

9.  TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis.

Authors:  Xiao-Yong Yu; Qian Sun; Ya-Mei Zhang; Liang Zou; Ying-Yong Zhao
Journal:  Front Pharmacol       Date:  2022-03-24       Impact factor: 5.810

Review 10.  Traditional Chinese Medicine in the Treatment of Chronic Kidney Diseases: Theories, Applications, and Mechanisms.

Authors:  Yunlai Wang; Ye Feng; Manman Li; Mo Yang; Gaoxiang Shi; Zihua Xuan; Dengke Yin; Fan Xu
Journal:  Front Pharmacol       Date:  2022-07-18       Impact factor: 5.988

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.